TI-001 (intranasal oxytocin)

oxytocin · Trigemina, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TI-001 (intranasal oxytocin), covering 2016-05-13 to 2016-05-13. Get the full timeline:

Most recent: Clinical Trial Update: TI-001 (Intranasal Oxytocin) for Treatment of High Frequency Episodic Migraine and Chronic Migraine [Phase 2]